A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer. [electronic resource]
Producer: 20180131Description: 5120-5129 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Apoptosis -- drug effects
- Camptothecin -- analogs & derivatives
- Carboplatin -- therapeutic use
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- DNA Damage -- drug effects
- Drug Delivery Systems -- methods
- Drug Synergism
- Female
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Mice
- Mice, SCID
- Resorcinols -- therapeutic use
- Signal Transduction -- drug effects
- Small Cell Lung Carcinoma -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.